Global Blood-Grouping Reagents Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	172 Pages	TechNavio	March, 2024	INF18690623

Best Price Guarantee
Price	from $2,500
Length	172 Pages
Publisher	TechNavio
Published Date	March, 2024
SKU	INF18690623

Global Blood-Grouping Reagents Market 2024-2028

The blood-grouping reagents market is forecasted to grow by USD 520.68 mn during 2023-2028, accelerating at a CAGR of 8.13% during the forecast period. The report on the blood-grouping reagents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of chronic disorders, rise in blood donations, and a growing number of hospitals and blood banks.

Technavio's blood-grouping reagents market is segmented as below:

By End-user

Hospitals and blood banks
Clinical laboratories
Academic and research institutes

By Technique

PCR-based and microarray techniques
Assay-based techniques
Massively parallel sequencing techniques
Serology

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the advancements in diagnostic devices as one of the prime reasons driving the blood-grouping reagents market growth during the next few years. Also, the growing adoption of multiplexing assays and integration of automation and high-throughput platforms in blood grouping will lead to sizable demand in the market.

The report on the blood-grouping reagents market covers the following areas:

Blood-grouping reagents market sizing
Blood-grouping reagents market forecast
Blood-grouping reagents market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading blood-grouping reagents market vendors that include AliveDX, Arena Bio Scien, ARKRAY Inc., Atlas Medical GmbH, BAG Health Care GmbH, Bio Rad Laboratories Inc., Calibre Scientific Inc., Danaher Corp., DIAGAST SAS, Grifols SA, Merck KGaA, Novacyt SA, QuidelOrtho Corp., Rapid Labs Ltd., Thermo Fisher Scientific Inc., Torax Biosciences Ltd., Tulip Diagnostics Pvt. Ltd., Fortress Diagnostics, Paragon Care Ltd., and VitroScient. Also, the blood-grouping reagents market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user; Exhibit 06: Executive Summary - Chart on Market Segmentation by Technique; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global blood-grouping reagents market 2018 - 2022; Exhibit 18: Historic Market Size - Data Table on global blood-grouping reagents market 2018 - 2022 ($ million); 4.2 End-User Segment Analysis 2018 - 2022; Exhibit 19: Historic Market Size - End-User Segment 2018 - 2022 ($ million); 4.3 Technique Segment Analysis 2018 - 2022; Exhibit 20: Historic Market Size - Technique Segment 2018 - 2022 ($ million); 4.4 Geography Segment Analysis 2018 - 2022; Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country Segment Analysis 2018 - 2022; Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user: 6.1 Market segments; Exhibit 30: Chart on End-user - Market share 2023-2028 (%); Exhibit 31: Data Table on End-user - Market share 2023-2028 (%); 6.2 Comparison by End-user; Exhibit 32: Chart on Comparison by End-user; Exhibit 33: Data Table on Comparison by End-user; 6.3 Hospitals and blood banks - Market size and forecast 2023-2028; Exhibit 34: Chart on Hospitals and blood banks - Market size and forecast 2023-2028 ($ million); Exhibit 35: Data Table on Hospitals and blood banks - Market size and forecast 2023-2028 ($ million); Exhibit 36: Chart on Hospitals and blood banks - Year-over-year growth 2023-2028 (%); Exhibit 37: Data Table on Hospitals and blood banks - Year-over-year growth 2023-2028 (%); 6.4 Clinical laboratories - Market size and forecast 2023-2028; Exhibit 38: Chart on Clinical laboratories - Market size and forecast 2023-2028 ($ million); Exhibit 39: Data Table on Clinical laboratories - Market size and forecast 2023-2028 ($ million); Exhibit 40: Chart on Clinical laboratories - Year-over-year growth 2023-2028 (%); Exhibit 41: Data Table on Clinical laboratories - Year-over-year growth 2023-2028 (%); 6.5 Academic and research institutes - Market size and forecast 2023-2028; Exhibit 42: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ million); Exhibit 43: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ million); Exhibit 44: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%); Exhibit 45: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by End-user; Exhibit 46: Market opportunity by End-user ($ million); Exhibit 47: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Technique: 7.1 Market segments; Exhibit 48: Chart on Technique - Market share 2023-2028 (%); Exhibit 49: Data Table on Technique - Market share 2023-2028 (%); 7.2 Comparison by Technique; Exhibit 50: Chart on Comparison by Technique; Exhibit 51: Data Table on Comparison by Technique; 7.3 PCR-based and microarray techniques - Market size and forecast 2023-2028; Exhibit 52: Chart on PCR-based and microarray techniques - Market size and forecast 2023-2028 ($ million); Exhibit 53: Data Table on PCR-based and microarray techniques - Market size and forecast 2023-2028 ($ million); Exhibit 54: Chart on PCR-based and microarray techniques - Year-over-year growth 2023-2028 (%); Exhibit 55: Data Table on PCR-based and microarray techniques - Year-over-year growth 2023-2028 (%); 7.4 Assay-based techniques - Market size and forecast 2023-2028; Exhibit 56: Chart on Assay-based techniques - Market size and forecast 2023-2028 ($ million); Exhibit 57: Data Table on Assay-based techniques - Market size and forecast 2023-2028 ($ million); Exhibit 58: Chart on Assay-based techniques - Year-over-year growth 2023-2028 (%); Exhibit 59: Data Table on Assay-based techniques - Year-over-year growth 2023-2028 (%); 7.5 Massively parallel sequencing techniques - Market size and forecast 2023-2028; Exhibit 60: Chart on Massively parallel sequencing techniques - Market size and forecast 2023-2028 ($ million); Exhibit 61: Data Table on Massively parallel sequencing techniques - Market size and forecast 2023-2028 ($ million); Exhibit 62: Chart on Massively parallel sequencing techniques - Year-over-year growth 2023-2028 (%); Exhibit 63: Data Table on Massively parallel sequencing techniques - Year-over-year growth 2023-2028 (%); 7.6 Serology - Market size and forecast 2023-2028; Exhibit 64: Chart on Serology - Market size and forecast 2023-2028 ($ million); Exhibit 65: Data Table on Serology - Market size and forecast 2023-2028 ($ million); Exhibit 66: Chart on Serology - Year-over-year growth 2023-2028 (%); Exhibit 67: Data Table on Serology - Year-over-year growth 2023-2028 (%); 7.7 Market opportunity by Technique; Exhibit 68: Market opportunity by Technique ($ million); Exhibit 69: Data Table on Market opportunity by Technique ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Exhibit 73: Chart on Geographic comparison; Exhibit 74: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%); Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 UK - Market size and forecast 2023-2028; Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%); 9.9 Canada - Market size and forecast 2023-2028; Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.10 France - Market size and forecast 2023-2028; Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ million); Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ million); Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%); Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%); 9.11 Japan - Market size and forecast 2023-2028; Exhibit 107: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibit 108: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibit 109: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibit 110: Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Exhibit 111: Market opportunity By Geographical Landscape ($ million); Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 113: Impact of drivers and challenges in 2023 and 2028; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 114: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 115: Overview on factors of disruption; 11.4 Industry risks; Exhibit 116: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 117: Vendors covered; 12.2 Market positioning of vendors; Exhibit 118: Matrix on vendor position and classification; 12.3 AliveDX; Exhibit 119: AliveDX - Overview; Exhibit 120: AliveDX - Product / Service; Exhibit 121: AliveDX - Key offerings; 12.4 Arena Bio Scien; Exhibit 122: Arena Bio Scien - Overview; Exhibit 123: Arena Bio Scien - Product / Service; Exhibit 124: Arena Bio Scien - Key offerings; 12.5 ARKRAY Inc.; Exhibit 125: ARKRAY Inc. - Overview; Exhibit 126: ARKRAY Inc. - Product / Service; Exhibit 127: ARKRAY Inc. - Key offerings; 12.6 Atlas Medical GmbH; Exhibit 128: Atlas Medical GmbH - Overview; Exhibit 129: Atlas Medical GmbH - Product / Service; Exhibit 130: Atlas Medical GmbH - Key offerings; 12.7 Bio Rad Laboratories Inc.; Exhibit 131: Bio Rad Laboratories Inc. - Overview; Exhibit 132: Bio Rad Laboratories Inc. - Business segments; Exhibit 133: Bio Rad Laboratories Inc. - Key news; Exhibit 134: Bio Rad Laboratories Inc. - Key offerings; Exhibit 135: Bio Rad Laboratories Inc. - Segment focus; 12.8 Calibre Scientific Inc.; Exhibit 136: Calibre Scientific Inc. - Overview; Exhibit 137: Calibre Scientific Inc. - Product / Service; Exhibit 138: Calibre Scientific Inc. - Key offerings; 12.9 Danaher Corp.; Exhibit 139: Danaher Corp. - Overview; Exhibit 140: Danaher Corp. - Business segments; Exhibit 141: Danaher Corp. - Key news; Exhibit 142: Danaher Corp. - Key offerings; Exhibit 143: Danaher Corp. - Segment focus; 12.10 DIAGAST SAS; Exhibit 144: DIAGAST SAS - Overview; Exhibit 145: DIAGAST SAS - Product / Service; Exhibit 146: DIAGAST SAS - Key offerings; 12.11 Grifols SA; Exhibit 147: Grifols SA - Overview; Exhibit 148: Grifols SA - Business segments; Exhibit 149: Grifols SA - Key offerings; Exhibit 150: Grifols SA - Segment focus; 12.12 Merck KGaA; Exhibit 151: Merck KGaA - Overview; Exhibit 152: Merck KGaA - Business segments; Exhibit 153: Merck KGaA - Key news; Exhibit 154: Merck KGaA - Key offerings; Exhibit 155: Merck KGaA - Segment focus; 12.13 Novacyt SA; Exhibit 156: Novacyt SA - Overview; Exhibit 157: Novacyt SA - Business segments; Exhibit 158: Novacyt SA - Key offerings; Exhibit 159: Novacyt SA - Segment focus; 12.14 Paragon Care Ltd.; Exhibit 160: Paragon Care Ltd. - Overview; Exhibit 161: Paragon Care Ltd. - Business segments; Exhibit 162: Paragon Care Ltd. - Key offerings; Exhibit 163: Paragon Care Ltd. - Segment focus; 12.15 QuidelOrtho Corp.; Exhibit 164: QuidelOrtho Corp. - Overview; Exhibit 165: QuidelOrtho Corp. - Product / Service; Exhibit 166: QuidelOrtho Corp. - Key offerings; 12.16 Thermo Fisher Scientific Inc.; Exhibit 167: Thermo Fisher Scientific Inc. - Overview; Exhibit 168: Thermo Fisher Scientific Inc. - Business segments; Exhibit 169: Thermo Fisher Scientific Inc. - Key news; Exhibit 170: Thermo Fisher Scientific Inc. - Key offerings; Exhibit 171: Thermo Fisher Scientific Inc. - Segment focus; 12.17 Tulip Diagnostics Pvt. Ltd.; Exhibit 172: Tulip Diagnostics Pvt. Ltd. - Overview; Exhibit 173: Tulip Diagnostics Pvt. Ltd. - Product / Service; Exhibit 174: Tulip Diagnostics Pvt. Ltd. - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 175: Inclusions checklist; Exhibit 176: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 177: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 178: Research methodology; Exhibit 179: Validation techniques employed for market sizing; Exhibit 180: Information sources; 13.5 List of abbreviations; Exhibit 181: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Market Segmentation by Technique; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits18: Historic Market Size - Data Table on global blood-grouping reagents market 2018 - 2022 ($ million); Exhibits19: Historic Market Size - End-User Segment 2018 - 2022 ($ million); Exhibits20: Historic Market Size - Technique Segment 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits23: Five forces analysis - Comparison between 2023 and 2028; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits29: Chart on Market condition - Five forces 2023 and 2028; Exhibits30: Chart on End-user - Market share 2023-2028 (%); Exhibits31: Data Table on End-user - Market share 2023-2028 (%); Exhibits32: Chart on Comparison by End-user; Exhibits33: Data Table on Comparison by End-user; Exhibits34: Chart on Hospitals and blood banks - Market size and forecast 2023-2028 ($ million); Exhibits35: Data Table on Hospitals and blood banks - Market size and forecast 2023-2028 ($ million); Exhibits36: Chart on Hospitals and blood banks - Year-over-year growth 2023-2028 (%); Exhibits37: Data Table on Hospitals and blood banks - Year-over-year growth 2023-2028 (%); Exhibits38: Chart on Clinical laboratories - Market size and forecast 2023-2028 ($ million); Exhibits39: Data Table on Clinical laboratories - Market size and forecast 2023-2028 ($ million); Exhibits40: Chart on Clinical laboratories - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on Clinical laboratories - Year-over-year growth 2023-2028 (%); Exhibits42: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ million); Exhibits43: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ million); Exhibits44: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%); Exhibits45: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%); Exhibits46: Market opportunity by End-user ($ million); Exhibits47: Data Table on Market opportunity by End-user ($ million); Exhibits48: Chart on Technique - Market share 2023-2028 (%); Exhibits49: Data Table on Technique - Market share 2023-2028 (%); Exhibits50: Chart on Comparison by Technique; Exhibits51: Data Table on Comparison by Technique; Exhibits52: Chart on PCR-based and microarray techniques - Market size and forecast 2023-2028 ($ million); Exhibits53: Data Table on PCR-based and microarray techniques - Market size and forecast 2023-2028 ($ million); Exhibits54: Chart on PCR-based and microarray techniques - Year-over-year growth 2023-2028 (%); Exhibits55: Data Table on PCR-based and microarray techniques - Year-over-year growth 2023-2028 (%); Exhibits56: Chart on Assay-based techniques - Market size and forecast 2023-2028 ($ million); Exhibits57: Data Table on Assay-based techniques - Market size and forecast 2023-2028 ($ million); Exhibits58: Chart on Assay-based techniques - Year-over-year growth 2023-2028 (%); Exhibits59: Data Table on Assay-based techniques - Year-over-year growth 2023-2028 (%); Exhibits60: Chart on Massively parallel sequencing techniques - Market size and forecast 2023-2028 ($ million); Exhibits61: Data Table on Massively parallel sequencing techniques - Market size and forecast 2023-2028 ($ million); Exhibits62: Chart on Massively parallel sequencing techniques - Year-over-year growth 2023-2028 (%); Exhibits63: Data Table on Massively parallel sequencing techniques - Year-over-year growth 2023-2028 (%); Exhibits64: Chart on Serology - Market size and forecast 2023-2028 ($ million); Exhibits65: Data Table on Serology - Market size and forecast 2023-2028 ($ million); Exhibits66: Chart on Serology - Year-over-year growth 2023-2028 (%); Exhibits67: Data Table on Serology - Year-over-year growth 2023-2028 (%); Exhibits68: Market opportunity by Technique ($ million); Exhibits69: Data Table on Market opportunity by Technique ($ million); Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits73: Chart on Geographic comparison; Exhibits74: Data Table on Geographic comparison; Exhibits75: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits76: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits77: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits78: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits79: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits80: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits81: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits82: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits83: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits84: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits85: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits86: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits99: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibits100: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibits101: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits102: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits103: Chart on France - Market size and forecast 2023-2028 ($ million); Exhibits104: Data Table on France - Market size and forecast 2023-2028 ($ million); Exhibits105: Chart on France - Year-over-year growth 2023-2028 (%); Exhibits106: Data Table on France - Year-over-year growth 2023-2028 (%); Exhibits107: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits108: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits109: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits110: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits111: Market opportunity By Geographical Landscape ($ million); Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits113: Impact of drivers and challenges in 2023 and 2028; Exhibits114: Overview on Criticality of inputs and Factors of differentiation; Exhibits115: Overview on factors of disruption; Exhibits116: Impact of key risks on business; Exhibits117: Vendors covered; Exhibits118: Matrix on vendor position and classification; Exhibits119: AliveDX - Overview; Exhibits120: AliveDX - Product / Service; Exhibits121: AliveDX - Key offerings; Exhibits122: Arena Bio Scien - Overview; Exhibits123: Arena Bio Scien - Product / Service; Exhibits124: Arena Bio Scien - Key offerings; Exhibits125: ARKRAY Inc. - Overview; Exhibits126: ARKRAY Inc. - Product / Service; Exhibits127: ARKRAY Inc. - Key offerings; Exhibits128: Atlas Medical GmbH - Overview; Exhibits129: Atlas Medical GmbH - Product / Service; Exhibits130: Atlas Medical GmbH - Key offerings; Exhibits131: Bio Rad Laboratories Inc. - Overview; Exhibits132: Bio Rad Laboratories Inc. - Business segments; Exhibits133: Bio Rad Laboratories Inc. - Key news; Exhibits134: Bio Rad Laboratories Inc. - Key offerings; Exhibits135: Bio Rad Laboratories Inc. - Segment focus; Exhibits136: Calibre Scientific Inc. - Overview; Exhibits137: Calibre Scientific Inc. - Product / Service; Exhibits138: Calibre Scientific Inc. - Key offerings; Exhibits139: Danaher Corp. - Overview; Exhibits140: Danaher Corp. - Business segments; Exhibits141: Danaher Corp. - Key news; Exhibits142: Danaher Corp. - Key offerings; Exhibits143: Danaher Corp. - Segment focus; Exhibits144: DIAGAST SAS - Overview; Exhibits145: DIAGAST SAS - Product / Service; Exhibits146: DIAGAST SAS - Key offerings; Exhibits147: Grifols SA - Overview; Exhibits148: Grifols SA - Business segments; Exhibits149: Grifols SA - Key offerings; Exhibits150: Grifols SA - Segment focus; Exhibits151: Merck KGaA - Overview; Exhibits152: Merck KGaA - Business segments; Exhibits153: Merck KGaA - Key news; Exhibits154: Merck KGaA - Key offerings; Exhibits155: Merck KGaA - Segment focus; Exhibits156: Novacyt SA - Overview; Exhibits157: Novacyt SA - Business segments; Exhibits158: Novacyt SA - Key offerings; Exhibits159: Novacyt SA - Segment focus; Exhibits160: Paragon Care Ltd. - Overview; Exhibits161: Paragon Care Ltd. - Business segments; Exhibits162: Paragon Care Ltd. - Key offerings; Exhibits163: Paragon Care Ltd. - Segment focus; Exhibits164: QuidelOrtho Corp. - Overview; Exhibits165: QuidelOrtho Corp. - Product / Service; Exhibits166: QuidelOrtho Corp. - Key offerings; Exhibits167: Thermo Fisher Scientific Inc. - Overview; Exhibits168: Thermo Fisher Scientific Inc. - Business segments; Exhibits169: Thermo Fisher Scientific Inc. - Key news; Exhibits170: Thermo Fisher Scientific Inc. - Key offerings; Exhibits171: Thermo Fisher Scientific Inc. - Segment focus; Exhibits172: Tulip Diagnostics Pvt. Ltd. - Overview; Exhibits173: Tulip Diagnostics Pvt. Ltd. - Product / Service; Exhibits174: Tulip Diagnostics Pvt. Ltd. - Key offerings; Exhibits175: Inclusions checklist; Exhibits176: Exclusions checklist; Exhibits177: Currency conversion rates for US$; Exhibits178: Research methodology; Exhibits179: Validation techniques employed for market sizing; Exhibits180: Information sources; Exhibits181: List of abbreviations